Randolph S. Marks
Mayo Clinic · 140 works · 8,059 citations · h-index 49
Top works
- Screening for Lung Cancer with Low-Dose Spiral Computed Tomography
- Clinical Features of 5,628 Primary Lung Cancer Patients
- Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002
- A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.
- Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
- Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease
- Genetic variants and risk of lung cancer in never smokers: a genome-wide association study
- Contrast of Response to Dacarbazine, Mitomycin, Doxorubicin, and Cisplatin (DMAP) Plus GM-CSF Between Patients with Advanced Malignant Gastrointestinal Stromal Tumors and Patients with Other Advanced Leiomyosarcomas
- The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer
- Histologic grade is an independent prognostic factor for survival in non–small cell lung cancer: An analysis of 5018 hospital- and 712 population-based cases
- Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma
- Immunomodulatory treatment trial for paraneoplastic neurological disorders
- Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study
- Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732
- Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer
- The detection and treatment of cancer-related functional problems in an outpatient setting
- Are Chemotherapy Response Rates Related to Treatment-Induced Survival Prolongations in Patients With Advanced Cancer?
- Alpha1-antitrypsin deficiency allele carriers among lung cancer patients.
- Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma
- Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer